These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 17365659)
21. The clinical implications of recent studies on the structure and function of the retinal microvasculature in diabetes. Cheung CY; Ikram MK; Klein R; Wong TY Diabetologia; 2015 May; 58(5):871-85. PubMed ID: 25669631 [TBL] [Abstract][Full Text] [Related]
23. Developments in the pathology of diabetic retinopathy: a review. Garner A J R Soc Med; 1981 Jun; 74(6):427-31. PubMed ID: 7019436 [No Abstract] [Full Text] [Related]
24. Systemic associations of retinal microvascular signs: a review of recent population-based studies. Wong TY; McIntosh R Ophthalmic Physiol Opt; 2005 May; 25(3):195-204. PubMed ID: 15854064 [TBL] [Abstract][Full Text] [Related]
25. Homocysteine, S-adenosylmethionine and S-adenosylhomocysteine are associated with retinal microvascular abnormalities: the Hoorn Study. Van Hecke MV; Dekker JM; Nijpels G; Teerlink T; Jakobs C; Stolk RP; Heine RJ; Bouter LM; Polak BC; Stehouwer CD Clin Sci (Lond); 2008 Apr; 114(7):479-87. PubMed ID: 17956228 [TBL] [Abstract][Full Text] [Related]
26. Incipient diabetic retinopathy--insights from an experimental model. Feng Y; vom Hagen F; Lin J; Hammes HP Ophthalmologica; 2007; 221(4):269-74. PubMed ID: 17579294 [TBL] [Abstract][Full Text] [Related]
28. Abnormal retinal autoregulation is detected by provoked stimulation with flicker light in well-controlled patients with type 1 diabetes without retinopathy. Mandecka A; Dawczynski J; Vilser W; Blum M; Müller N; Kloos C; Wolf G; Müller UA Diabetes Res Clin Pract; 2009 Oct; 86(1):51-5. PubMed ID: 19646772 [TBL] [Abstract][Full Text] [Related]
29. [Haemodynamics and diabetic retinopathy]. Blum M; Eichhorn M; Vilser W Klin Monbl Augenheilkd; 2005 Jun; 222(6):463-70. PubMed ID: 15973624 [TBL] [Abstract][Full Text] [Related]
30. The pathology associated with diabetic retinopathy. Lechner J; O'Leary OE; Stitt AW Vision Res; 2017 Oct; 139():7-14. PubMed ID: 28412095 [TBL] [Abstract][Full Text] [Related]
31. Advances in biochemical mechanisms of diabetic retinopathy. Giusti C; Gargiulo P Eur Rev Med Pharmacol Sci; 2007; 11(3):155-63. PubMed ID: 17970231 [TBL] [Abstract][Full Text] [Related]
32. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy. Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613 [TBL] [Abstract][Full Text] [Related]
33. Microvascular pathology in diabetes with particular reference to diabetic retinopathy. Ratnakar KS Indian J Ophthalmol; 1986; 34():333-6. PubMed ID: 3155115 [No Abstract] [Full Text] [Related]
34. Image registration and subtraction for the visualization of change in diabetic retinopathy screening. McRitchie IN; Hart PM; Winder RJ Comput Med Imaging Graph; 2006 Apr; 30(3):139-45. PubMed ID: 16631349 [TBL] [Abstract][Full Text] [Related]
36. Diabetic retinopathy: current management and experimental therapeutic targets. Ali TK; El-Remessy AB Pharmacotherapy; 2009 Feb; 29(2):182-92. PubMed ID: 19170588 [TBL] [Abstract][Full Text] [Related]
37. Novel versus traditional risk markers for diabetic retinopathy. Sasongko MB; Wong TY; Nguyen TT; Shaw JE; Jenkins AJ; Wang JJ Diabetologia; 2012 Mar; 55(3):666-70. PubMed ID: 22198262 [TBL] [Abstract][Full Text] [Related]
38. Loss of insulin-mediated vasoprotection: early effect of diabetes on pericyte-containing microvessels of the retina. Kobayashi T; Puro DG Invest Ophthalmol Vis Sci; 2007 May; 48(5):2350-5. PubMed ID: 17460301 [TBL] [Abstract][Full Text] [Related]